NYSE:ALB - Albemarle Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $94.84 -0.70 (-0.73 %) (As of 08/22/2018 02:58 AM ET)Previous Close$95.54Today's Range$94.43 - $95.6152-Week Range$86.75 - $144.99Volume1.38 million shsAverage Volume1.88 million shsMarket Capitalization$10.35 billionP/E Ratio20.71Dividend Yield1.40%Beta1.65 Company ProfileAnalyst RatingsChartDividend HistoryEarnings HistoryFinancialsInsider TradesHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. Its Lithium and Advanced Materials segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties, as well as reagents, such as butyllithium and lithium aluminum hydride for applications in lithium batteries for consumer electronics and automobiles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes, life science, pharmaceutical, and other markets. It also offers cesium products for the chemical and pharmaceutical markets; zirconium, barium, and titanium products for various pyrotechnical applications; technical services, such as the handling and use of reactive lithium products; and recycling services for lithium-containing by-products. In addition, this segment offers performance catalyst solutions comprising organometallics, polymer catalysts, and curatives for polyolefin polymers, packaging, non-packaging, films, injection molding, alpha-olefins, polyurethanes, epoxies, and engineered resins markets. Its Bromine Specialties segment offers bromine and bromine-based solutions for fire safety, chemical synthesis, mercury control, water purification, beef and poultry processing, and other industrial applications, as well as oil and gas well drilling, and completion fluids applications; and tertiary amines, biocides, disinfectants, and sanitizers. Its Refining Solutions segment offers clean fuels technologies, which is primarily composed of hydroprocessing catalysts; and fluidized catalytic cracking catalysts and additives for refining industry. It serves energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, crop protection, and custom chemistry services markets. The company was founded in 1994 and is headquartered in Charlotte, North Carolina. Receive ALB News and Ratings via Email Sign-up to receive the latest news and ratings for ALB and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSE Industry Plastics materials & resins Sub-IndustrySpecialty Chemicals SectorBasic Materials SymbolNYSE:ALB CUSIP01265310 Webwww.albemarle.com Phone980-299-5700 Debt Debt-to-Equity Ratio0.37 Current Ratio2.19 Quick Ratio1.55 Price-To-Earnings Trailing P/E Ratio20.71 Forward P/E Ratio17.66 P/E Growth1.25 Sales & Book Value Annual Sales$3.07 billion Price / Sales3.35 Cash Flow$6.4081 per share Price / Cash14.80 Book Value$34.55 per share Price / Book2.75 Profitability EPS (Most Recent Fiscal Year)$4.59 Net Income$54.85 million Net Margins10.17% Return on Equity14.51% Return on Assets7.47% Miscellaneous Employees5,400 Outstanding Shares108,450,000Market Cap$10.35 billion Albemarle (NYSE:ALB) Frequently Asked Questions What is Albemarle's stock symbol? Albemarle trades on the New York Stock Exchange (NYSE) under the ticker symbol "ALB." How often does Albemarle pay dividends? What is the dividend yield for Albemarle? Albemarle declared a quarterly dividend on Thursday, July 26th. Shareholders of record on Friday, September 14th will be given a dividend of $0.335 per share on Monday, October 1st. This represents a $1.34 dividend on an annualized basis and a yield of 1.41%. The ex-dividend date is Thursday, September 13th. View Albemarle's Dividend History. How were Albemarle's earnings last quarter? Albemarle Co. (NYSE:ALB) issued its quarterly earnings data on Tuesday, August, 7th. The specialty chemicals company reported $1.36 earnings per share for the quarter, beating the Zacks' consensus estimate of $1.28 by $0.08. The specialty chemicals company had revenue of $853.87 million for the quarter, compared to analyst estimates of $799.49 million. Albemarle had a return on equity of 14.51% and a net margin of 10.17%. View Albemarle's Earnings History. When is Albemarle's next earnings date? Albemarle is scheduled to release their next quarterly earnings announcement on Wednesday, November, 14th 2018. View Earnings Estimates for Albemarle. What guidance has Albemarle issued on next quarter's earnings? Albemarle updated its FY18 earnings guidance on Tuesday, August, 7th. The company provided earnings per share guidance of $5.30-5.50 for the period, compared to the Thomson Reuters consensus EPS estimate of $5.26. The company issued revenue guidance of $3.3-3.5 vln, compared to the consensus revenue estimate of $3.32 billion. What price target have analysts set for ALB? 21 brokerages have issued 12-month price objectives for Albemarle's stock. Their forecasts range from $106.00 to $157.00. On average, they anticipate Albemarle's share price to reach $133.2506 in the next year. This suggests a possible upside of 40.5% from the stock's current price. View Analyst Price Targets for Albemarle. What is the consensus analysts' recommendation for Albemarle? 21 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Albemarle in the last year. There are currently 2 hold ratings and 19 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Albemarle. What are Wall Street analysts saying about Albemarle stock? Here are some recent quotes from research analysts about Albemarle stock: 1. According to Zacks Investment Research, "Albemarle remains focused on strengthening its lithium business. It is well placed to leverage strong growth in the battery-grade lithium market. The company is also likely to gain from the synergies of Rockwood Holdings acquisition. Further, Albemarle is divesting non-core assets to boost growth opportunities and focus on its key businesses. The company also remains committed to deliver incremental returns to shareholders. " (8/7/2018) 2. KeyCorp analysts commented, "ITRI beat 4Q17 consensus on top/bottom line while guiding FY18 adj. EPS midpoint 2% below Street. Amid moving parts—Silver Spring (now “Networks”) integration, a new restructuring program, and ongoing impacts from 2016 restructuring—we have three primary takeaways. First, we think FY18 guidance embeds healthy organic growth at legacy Itron, supported by 12-month backlog up 22%. Second, we see revenue recog. timing at Networks as a potential dilutive factor in FY18 guidance (on top of Networks’ already higher cost structure) that understates margin expansion at legacy Itron. Third, we believe the restructuring plan is mainly a continuation of existing optimization programs and supports our view of the long-term adj. EBITDA trajectory (which moves slightly lower along with our PT to $77). Maintain Outperform." (3/1/2018) Who are some of Albemarle's key competitors? Some companies that are related to Albemarle include Eastman Chemical (EMN), Sinopec Shanghai Petrochemical (SHI), Hexcel (HXL), PolyOne (POL), Trinseo (TSE), Rogers (ROG), Kraton (KRA), A Schulman (SHLM), AdvanSix (ASIX), Cereplast (CERPQ) and ForceField Energy (FNRG). Who are Albemarle's key executives? Albemarle's management team includes the folowing people: Mr. Luther C. Kissam IV, Chairman, Pres & CEO (Age 53)Mr. Scott A. Tozier, Exec. VP & CFO (Age 52)Mr. Donald J. LaBauve Jr., Chief Accounting Officer, VP & Corp. Controller (Age 51)Ms. Karen G. Narwold, Chief Admin. Officer, Exec. VP, Gen. Counsel & Corp. Sec. (Age 58)Mr. David Ryan, VP of Corp. Strategy & Investor Relations Has Albemarle been receiving favorable news coverage? Headlines about ALB stock have been trending somewhat positive this week, Accern reports. Accern identifies negative and positive media coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Albemarle earned a daily sentiment score of 0.15 on Accern's scale. They also gave headlines about the specialty chemicals company an impact score of 47.31 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company's share price in the near future. View Recent Headlines for Albemarle. Who are Albemarle's major shareholders? Albemarle's stock is owned by many different of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (7.50%), Jennison Associates LLC (6.62%), Bank of New York Mellon Corp (4.88%), Baillie Gifford & Co. (2.36%), Iridian Asset Management LLC CT (1.83%) and Global X Management Co LLC (1.43%). Company insiders that own Albemarle stock include Douglas L Maine, Karen G Narwold, Luther C Iv Kissam, Matthew Juneau and Scott Tozier. View Institutional Ownership Trends for Albemarle. Which institutional investors are selling Albemarle stock? ALB stock was sold by a variety of institutional investors in the last quarter, including Janus Henderson Group PLC, Baird Financial Group Inc., FMR LLC, Dividend Assets Capital LLC, Bank of New York Mellon Corp, Artisan Partners Limited Partnership, BlackRock Inc. and Los Angeles Capital Management & Equity Research Inc.. Company insiders that have sold Albemarle company stock in the last year include Karen G Narwold and Matthew Juneau. View Insider Buying and Selling for Albemarle. Which institutional investors are buying Albemarle stock? ALB stock was acquired by a variety of institutional investors in the last quarter, including Baillie Gifford & Co., Jennison Associates LLC, Advisors Asset Management Inc., Rovida Advisors Inc., Sei Investments Co., Joho Capital LLC, Federated Investors Inc. PA and Handelsbanken Fonder AB. View Insider Buying and Selling for Albemarle. How do I buy shares of Albemarle? Shares of ALB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Albemarle's stock price today? One share of ALB stock can currently be purchased for approximately $94.84. How big of a company is Albemarle? Albemarle has a market capitalization of $10.35 billion and generates $3.07 billion in revenue each year. The specialty chemicals company earns $54.85 million in net income (profit) each year or $4.59 on an earnings per share basis. Albemarle employs 5,400 workers across the globe. How can I contact Albemarle? Albemarle's mailing address is 4350 CONGRESS STREET SUITE 700, CHARLOTTE NC, 28209. The specialty chemicals company can be reached via phone at 980-299-5700. MarketBeat Community Rating for Albemarle (NYSE ALB)Community Ranking: 2.8 out of 5 ( )Outperform Votes: 547 (Vote Outperform)Underperform Votes: 438 (Vote Underperform)Total Votes: 985MarketBeat's community ratings are surveys of what our community members think about Albemarle and other stocks. Vote "Outperform" if you believe ALB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ALB will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 8/22/2018 by MarketBeat.com StaffFeatured Article: What is the NASDAQ?